Second Chance Hearts: Are Younger Donor Hearts the Key to Adult Transplants?
"New research explores if hearts from early adolescent donors can safely expand the donor pool for adult heart transplant recipients, offering hope and better outcomes."
For individuals facing end-stage heart failure, a heart transplant represents more than just a medical procedure; it's a lifeline. While advancements in left ventricular assist devices have provided crucial support, heart transplantation remains the gold standard for extending and improving the quality of life. Unfortunately, the demand for donor hearts far exceeds the supply. It's estimated that over 20,000 people in the United States could benefit from a heart transplant, yet only a fraction receive one each year.
This disparity highlights a critical need to expand the donor pool safely and effectively. One potential solution lies in re-evaluating the use of hearts from early adolescent donors (individuals aged 10 to 14). These hearts, often not considered for pediatric recipients, could offer a valuable resource for adult patients in need. However, concerns about hormonal factors and heart development have historically limited their use.
Now, a groundbreaking study challenges these long-held beliefs. Researchers have delved into the outcomes of adult transplant recipients who received hearts from early adolescent donors, comparing them to those who received hearts from traditional adult donors. The findings may transform how we approach heart transplantation, offering new hope to those on the waiting list.
The Rise of DCD Heart Donation
DCD heart donation has risen steadily since 2019 and has supported an increasing number of heart transplants. In 2024, DCD hearts represented 17.9% of donated hearts, compared with 14.0% in 2023 and 0.2% in 2019. The OPTN/SRTR Annual Data Report, developed by SRTR and the Organ Procurement and Transplantation Network, tracks heart transplantation alongside other organ-transplant and donation data.
From Animal Experiments to Human Transplantation
Heart transplantation developed through decades of research and surgical innovation addressing immunology, organ preservation, and patient care. Early experiments in canines and primates, along with animal-organ and vascular-suturing studies, helped establish techniques used in later procedures. The first human heart transplant, performed by Dr. Christiaan Barnard in 1967, became a landmark in the field's evolution.
Breaking Barriers: Examining Early Adolescent Hearts for Adult Transplants
Traditionally, the hearts of early adolescent donors haven't been widely used for adult transplants due to concerns about their development and hormonal activity. Early adolescence is a period marked by significant hormonal changes that fuel growth spurts, sexual development, and the emergence of secondary sexual characteristics. Some experts have theorized that the hormonal surge during this time also impacts heart growth, increasing both the thickness of the heart walls and overall contractility.
- All-cause mortality
- Cardiac allograft vasculopathy (CAV), a condition affecting the blood vessels of the transplanted heart
- Primary graft failure (PGF), which is when the donor heart fails within 90 days of transplant
Pediatric Donors in Heart Transplantation
A reported analysis of 3,787 heart-transplant recipients found that pediatric donors younger than 15 years accounted for 1.3% of cases. Donors aged 15 to 18 years accounted for 5.0%. These figures indicate that adolescent donors represented a larger share of the analyzed transplants than younger pediatric donors, although the source excerpt does not establish whether donor age improved recipient outcomes.
Pediatric Hearts and Artificial Alternatives
A literature review and survey found a wide range in the discard or refusal of pediatric hearts offered for transplantation, from 18% to 57%, with substantial geographic variation. Separate reviews describe total artificial hearts and ventricular assist devices as important alternatives amid donor-heart scarcity. However, comprehensive comparisons of artificial-heart and donor-heart outcomes remain limited, with reviews focusing on survival, quality of life, and post-transplant complications.
A Future with More Available Hearts?
This research delivers a powerful message: hearts from early adolescent donors, when carefully matched to adult recipients, can lead to successful outcomes. By expanding the criteria for donor heart acceptance, the medical community can tap into a valuable resource and offer a life-saving treatment to more individuals in need. As transplant centers embrace these findings, the future of heart transplantation looks brighter, with the potential to significantly reduce waiting times and improve the lives of countless patients.
Preservation, Selection, and Xenotransplantation
The persistent shortage of donor hearts has driven interest in xenotransplantation, while genetic engineering has enabled advances in the field. The first genetically modified porcine-to-human heart transplant, performed in January 2022, marked a pivotal milestone, although immunological incompatibility remains a principal barrier. Current approaches also emphasize donor and recipient selection, preservation strategies, immunosuppression, and mechanical circulatory support, with donor procurement and organ preservation remaining critical to transplantation success.
Preserving More Donor Hearts
Heart transplantation remains an important therapy for end-stage heart failure, offering improved quality of life and incremental survival. The condition and preservation of the donor heart are central to transplant success, with ischemia-reperfusion injury and donor-related risk factors requiring attention. Research involving deceased donors is difficult to conduct, and the field continues to face shortages of suitable donor organs, donor-specific antibodies, cardiac allograft vasculopathy, and other long-term complications.
Making More Hearts Usable
The Stanford Donor Heart Study sought to identify clinical correlates of cardiac function in potential donors, examine why offered hearts were not accepted, and develop real-time decision tools for transplant centers. One reported challenge is that many hearts are declined after initial assessment shows reduced cardiac function, including a left ventricular ejection fraction below 50%. DCD donation has expanded the donor pool, and a study of more than 1,000 DCD heart transplants examined outcomes using the OCS Heart against donation after brain death using standard cold storage.